mercredi 13 septembre 2017

Onco Actu du 13 septembre 2017

1. Biologie

Scientists Develop Fluorescent Sensors That May Pave Way for New Cancer Therapies [Roswell Park]

2.8 Etiologie - Contraceptifs, THS

HRT will not shorten lives, women told after new research published [The Guardian]

Taking Hormones for Menopause Doesn’t Raise Early Death Risk [NY Times]

Menopause hormone therapy not linked to premature death [Reuters]

3.1 Prévention - Tabac

UN Global Compact ban recognises the tobacco industry’s incompatibility with responsible, sustainable business [NCD Alliance]

GPs 'don't bother persuading cancer patients to give up smoking' [The Telegraph]

3.1.1 Prévention - Tabac - e-cigs

E-cigarette science – is scaremongering hampering research opportunities? [The Guardian]

3.3 Prévention - Vaccins

Another antivaccine film disguised as a documentary, this time lying about HPV vaccines [Respectful Insolence]

4.1 Dép., diag. & prono. - Prostate

Most news coverage on new PSA testing study acknowledged costly trade-offs [HealthNewsReview]

4.7 Dép., diag. & prono. - Col de l'utérus

Draft Recommendation Statement Cervical Cancer: Screening [USPSTF]

For Many Women, Cervical Cancer Screening May Get A Lot Simpler [NPR]

Middle-age women can choose Pap smear or HPV test for cancer screening [Reuters]

5.12.5 Immunothérapies - Pharma

Bristol-Myers advances new LAG-3 drug relatlimab to fight PD-1 resistance [FierceBiotech]

FDA says Tecentriq won't lose its bladder cancer nod despite phase 3 failure, Roche reports [FiercePharma]

5.2 Pharma

Erytech mulls first-line use for pivotal pancreatic cancer trial [FierceBiotech]

Onxeo Announces Top-Line Results from ReLive Phase III Study of Livatag® in Advanced Hepatocellular Carcinoma [Onxeo]

Phase 3 hepatocellular carcinoma fail crushes Onxeo [FierceBiotech]

5.3 Traitements - FDA, EMA, NICE...

FDA is Advancing the Goals of the Orphan Drug Act [FDA]

Scott Gottlieb is closing a big loophole in the orphan drug law [EndPoints]

How the RACE for Children Act will get drugs to kids with cancer [The Cancer Letter]

Peter Doshi: Speed vs safety in the FDA’s new drug approvals—speed wins, again [BMJ Blogs]

5.4 Traitements - Economie

What they are saying: Study on cancer R&D costs is not an accurate representation of marketplace [PhRMA]

It Costs More Than This [In the Pipeline]

6. Lutte contre les cancers

University of California Cancer Consortium Takes on California’s $14 Billion Killer [UCSF]

Faculty promotion must assess reproducibility [Nature]

6.1 Observation

Cancer deaths are down — but new cases are on the rise, report says [STAT]

6.11 Patients

Positive Sign or False Hope? Time Will Tell… [AdventuresInLivingTerminallyOptimistic]

6.5 Médecines alternatives

Forgoing Conventional Cancer Treatments for Alternative Medicine Increases Risk of Death [NCI]

6.6 Publications

Plan for new medical preprint server receives a mixed response [Science]

Innovations in Peer Review and Scientific Publishing [Absolutely Mabe]

6.7 DMP, Big Data & applis

Patients' illnesses could soon be diagnosed by AI, NHS leaders say [The Guardian]

6.7.2 Applis

It's official: Health, not just wellness, is Apple's future [CNBC]

6.9 Controverses

Another ‘breach of trust’ at STAT: patient who praised TV drug ads says pharma PR company asked her to write op-ed [HealthNewsReview]